DSM-5 Round up: April #2
April 11, 2013
DSM-5 Round up: April #2
Post #232 Shortlink: http://wp.me/pKrrB-2IU
Update at April 13:
Slate
Why will half of the U.S. population have a diagnosable mental disorder?
Robin S Rosenberg | April 12, 2013
Via Patrick Landman @landman35635068
News of a forthcoming event about the “medicalization of childhood” and the consequences of DSM-5. The organizers belong to the STOP DSM international movement.
6-8 June, 2013 Palais Rouge, Buenos Aires, Agentina
and
Fundación Sociedades Complejas
La FUNDACION SOCIEDADES COMPLEJAS. PROYECTOS EN SALUD Y EDUCACION se instituye con el objeto de promover el desarrollo, la capacitación, la formación, la investigación y el perfeccionamiento continuo de todos aquellos profesionales de la salud, la educación y la cultura que trabajan con bebes, niñas…
See also guest editorial by Patrick Landman on Side Effects at Psychology Today
Why DSM-5 Concerns European Psychiatrists
A guest contributor from Paris explains why the manual’s power is misplaced
Published on March 18, 2013 by Christopher Lane, Ph.D. in Side Effects
Patrick Landman, Université de Paris VII
The New Yorker
The D.S.M. and the Nature of Disease
Gary Greenberg | April 9, 2013
…The D.S.M. has enormous impact on the public health. It determines which conditions insurers will cover, which drugs regulators will approve, which children will receive special-education services, and which criminal defendants will be able to stand trial and, in some cases, how they will be sentenced. Psychiatry has already reached far into our daily lives, and it’s not by virtue of the particulars of any given D.S.M. It’s because the A.P.A., a private guild, one with extensive ties to the drug industry, owns the naming rights to our pain. That so significant a public trust is in private hands, and on such questionable grounds, is what we ought to worry about.